News
Shiv Sena MLA Sanjay Gaikwad claimed the food was stale and ignored repeated complaints. The incident drew criticism from the ...
A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.
The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.
The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...
Explore more
Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to ...
Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve ...
New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...
Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results